FdaApplication
ANDA 213501
Identifiers
- fda_app_no: ANDA213501
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMS LTD |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GABAPENTIN ENCARBIL | GABAPENTIN ENCARBIL | 300MG | TABLET, EXTENDED RELEASE;ORAL |
| GABAPENTIN ENCARBIL | GABAPENTIN ENCARBIL | 600MG | TABLET, EXTENDED RELEASE;ORAL |
2 products